Merck & Co., Inc. (MRK): SEC Filings & AI Analysis
Health Care. Latest 10-K, 10-Q, and 8-K filings for Merck & Co., Inc. (MRK) with AI risk scoring and cited answers, grounded in primary-source SEC EDGAR data.
Most recent filing — 8-K filed October 13, 2026: BULLISH Concern level: LOW.
Company overview — key questions
Answers are generated from SEC filings and StockHuntr's analysis. Not investment advice.
What is Merck & Co., Inc. (MRK)?
Merck & Co., Inc. is a publicly traded company in the Health Care space tracked on StockHuntr, which analyzes its SEC filings (10-K, 10-Q, 8-K) and generates 30-day stock predictions.
What are MRK's most recent SEC filings?
Recent filings: 8-K (October 13, 2026), 10-Q (August 7, 2026), 8-K (August 4, 2026), 8-K (May 28, 2026), 8-K (May 22, 2026).
What does MRK's latest filing analysis show?
MRK's most recent 8-K (October 13, 2026) is rated BULLISH, concern level LOW.
Is MRK a buy?
StockHuntr doesn't issue buy or sell ratings — it's a research tool. For Merck & Co., Inc. (MRK), its latest 8-K is rated LOW concern. Weigh these filing-based signals alongside your own research. This is model analysis for research, not investment advice.
Recent MRK filings analyzed
- 8-K · Oct 13, 2026 · concern 1.5/10
- 10-Q · Aug 7, 2026 · concern 7.0/10
- 8-K · Aug 4, 2026 · concern 2.1/10
Compare across the sector: Health Care sector analysis →
Other Health Care companies
About this analysis
- Primary source:
- View this company's filings on SEC EDGAR
- Additional data:
- Yahoo Finance (market data)
- Method:
- StockHuntr analyzes filings with AI — see our methodology.
- Analysis as of:
- October 13, 2026
- Published by:
- StockHuntr
For research and education only. Nothing here is investment advice.
Loading MRK snapshot...
Fetching live market data